Public health
COVID-19

Warning from the deep
Monitoring the novel coronavirus in sewage systems improves epidemiological surveillance in Brazilian cities
By Tiago Jokura
COVID-19

Hybrid coronavirus antibodies
A promising strategy for preventing and treating the novel coronavirus has been successfully tested in mice by researchers at the University of Texas Health Science Center at Houston, USA
By Redação
COVID-19

Changes in alcohol consumption
Self isolation and social distancing seem to be changing the way alcohol is consumed in Latin America and the Caribbean, with a fall in the number of people drinking
By Redação
RETROSPECT

The shadow of the white plague
Tuberculosis persists, even 100 years after its vaccine was invented
COVID-19

Risk of death is higher among the poor in Chile
People under 40 living in poorer municipalities in the Metropolitan Region of Santiago, Chile, are 3.1 times more likely to die from complications associated with COVID-19 than those who live in more affluent regions
By Redação
COVID-19

Lasting consequences
People who survive SARS-CoV-2, even those not hospitalized, can suffer the effects of the infection for months after the most intense symptoms subside
By Redação
COVID-19

The virus and the loss of smell
The loss of smell that affects up to two-thirds of people infected with SARS-CoV-2 is a consequence of both the direct action of the virus and the inflammation it triggers in the olfactory system, according to a team of researchers
By Redação
COVID-19

Dengue increases risk of COVID-19 symptoms
The risk of developing COVID-19 symptoms when infected with the novel coronavirus is twice as high among individuals who have had dengue in the past
By Redação
Covid-19

Mask effectiveness tests
Researchers compared the quality of 227 types of face masks sold in Brazil, measuring their ability to block the novel coronavirus
By Redação
COVID-19

New clues about blood clots linked to the AstraZeneca vaccine
A step has been taken towards explaining why the vaccine developed by the pharmaceutical company AstraZeneca can very rarely lead to the formation of blood clots
By Redação
COVID-19

The months-long consequences of COVID-19
The long-term effects of COVID-19 are becoming clearer
By Redação
COVID-19

The importance of the cellular response against the coronavirus
Fighting a SARS-CoV-2 infection is not solely the responsibility of antibodies, the proteins that adhere to the virus’s surface to prevent it from entering cells or mark it for destruction
By Redação
COVID-19

Superior immunity
Studies of blood and tissue samples taken before the COVID-19 pandemic may help explain why the disease is more common and more severe in adults than in children
By Redação
Public health

Tuberculosis in prisons
Tuberculosis cases in the Latin American prison population increased by 269% between 2011 and 2017
By Redação
Public administration

Crafting healthcare policy
Since the 1970s, researchers and other actors have worked to integrate government, science, and the economy in the health-industry complex
By Diego Viana
Public health

An agenda for forgotten diseases
WHO launches road map to 2030 for preventing and eradicating neglected tropical diseases
COVID-19

New vaccines on the way
Butantan Institute and federal government plan to start human trials of two vaccine candidates in the coming months
By Marcos Pivetta and Ricardo Zorzetto
COVID-19

High infant mortality in Sergipe
Despite having enough beds available in intensive care units (ICU) for adults, Sergipe has a 41% shortfall in pediatric beds
By Redação
nuclear tests

France underestimated how many were affected by nuclear testing
The inhabitants of the archipelagos of French Polynesia were exposed to 2–20 times more radiation than previously estimated
By Redação
Covid-19

Poor performance
Brazil's response to the pandemic was considered the worst in the world by a survey released in January by the Lowy Institute, Australia
By Redação